MCACL has a much more favorable prognosis than most other forms of adenocarcinoma and most other NSCLC's. Cases have been documented of continued growth of these lesions over a period of 10 years without symptoms or metastasis. The overall mortality rate appears to be somewhere in the vicinity of 18% to 27%, depending on the criteria that are used to define this entity.
Mucinous cystadenocarcinoma of the lung
Epithelial-myoepithelial carcinoma of the lung
Atypical pulmonary carcinoid tumour
Salivary gland–like carcinoma of the lung
Large cell neuroendocrine carcinoma of the lung
Giant-cell carcinoma of the lung
Sarcomatoid carcinoma of the lung
Basaloid large cell carcinoma of the lung